Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IBI310 |
Trade Name | |
Synonyms | IBI-310|IBI 310 |
Drug Descriptions |
IBI310 is an antibody targeting CTLA4 (CD152), which potentially induces antitumor activity (PMID: 38881798). |
DrugClasses | CTLA4 Antibody 32 |
CAS Registry Number | NA |
NCIT ID | C175970 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IBI310 | IBI310 | 0 | 0 |
IBI310 + SHR-1316 | IBI310 SHR-1316 | 0 | 0 |
IBI310 + Sintilimab | IBI310 Sintilimab | 0 | 0 |